Torno Capital’s 60 Degrees Pharmaceuticals Warrant SXTPW Stock Holding History

Torno Capital’s Portfolio SXTPW Stock Details SXTPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.43K	Hold	47,169	–	–	﹤0.01%	67
2026 Q1	$2.36K	Hold	47,169	–	–	﹤0.01%	51
2025 Q4	$2.96K	Hold	47,169	–	–	﹤0.01%	85
2025 Q3	$1.75K	Hold	47,169	–	–	﹤0.01%	83
2025 Q2	$2.66K	Hold	47,169	–	–	﹤0.01%	63
2025 Q1	$1.08K	Hold	47,169	–	–	﹤0.01%	75
2024 Q4	$1.4K	Hold	47,169	–	–	﹤0.01%	141
2024 Q3	$2.7K	Hold	47,169	–	–	﹤0.01%	208
2024 Q2	$3.31K	Hold	47,169	–	–	﹤0.01%	178
2024 Q1	$3.58K	Hold	47,169	–	–	﹤0.01%	254
2023 Q4	$2.36K	Buy	+47,169	New	+$5.97K	﹤0.01%	221

Other funds holding SXTPW

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Torno Capital's SXTPW Position: Q2 2026 in Review

Torno Capital held its 60 Degrees Pharmaceuticals Warrant (SXTPW) position steady in Q2 2026 at 47,169 shares worth $1.43K. The position accounts for ﹤0.01% of the portfolio, ranked #67.

Torno Capital first reported a position in SXTPW in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.58K in Q1 2024. 5 funds tracked by Wall St. Rank hold SXTPW as of Q2 2026.

Torno Capital held 47,169 shares of 60 Degrees Pharmaceuticals Warrant worth $1.43K as of Q2 2026.
Torno Capital left its 60 Degrees Pharmaceuticals Warrant share count unchanged in Q2 2026.
60 Degrees Pharmaceuticals Warrant made up ﹤0.01% of Torno Capital's portfolio in Q2 2026, its #67 holding.
Torno Capital first reported a position in 60 Degrees Pharmaceuticals Warrant in Q4 2023 and has held it in 11 quarters since.
Torno Capital's 60 Degrees Pharmaceuticals Warrant position peaked at $3.58K in Q1 2024.
5 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals Warrant as of Q2 2026.

Based on Torno Capital's 13F filing for Q2 2026, filed 14 Aug 2026.